News | Radiation Therapy | September 02, 2015

Varian Launches Developer Cloud to Foster Next-Generation Cancer Treatment Technologies

Part of OncoPeer online forum, toolkit features applications and information to accelerate development of new techniques and processes

Varian, Developer Cloud, OncoPeer online forum, next-generation cancer treatment technologies

September 2, 2015 — Varian Medical Systems has added a new cloud-based toolkit to the company's OncoPeer interactive online forum, making development tools available for research that has the potential to lead to next-generation cancer treatment technologies.

Varian's new Developer Cloud houses digital tools like information about TrueBeam Developer Mode, an optional non-clinical development tool, and cloud-based applications for managing Developer Mode and simulating treatments. It is part of the company's overall objective to empower research-oriented clinical teams to accelerate the development of new treatment techniques and processes designed to improve outcomes for cancer patients.

In a separate development, the OncoPeer online forum — first launched last March in select geographic areas — is now accessible to Varian customers worldwide. Since March, users have established discussion groups on topics like oncology analytics, knowledge-based treatment planning, treatment planning using Eclipse software and the physics of radiotherapy. One discussion group focuses on how to use Varian's Aria information system to manage a medical oncology department. Other groups share information about Varian treatment delivery platforms.

Varian held an online seminar about Navigating OncoPeer last May. Interested clinicians can view a replay of the webcast.

For more information:

Related Content

BrainLAB Announces FDA Clearance For Two New Indication-Specific Radiosurgery Software Applications
Technology | Treatment Planning | September 21, 2017
Brainlab announced that it has received U.S. Food and Drug Administration (FDA) clearance for Elements Spine SRS and...
Accuray Showcases CyberKnife and Radixact Systems at ASTRO 2017
News | Radiation Therapy | September 21, 2017
Accuray Inc. announced that data and first-hand experience with its advanced CyberKnife and Radixact Systems will be...
RayCare Oncology Information System Being Shown at ASTRO 2017
News | Radiation Therapy | September 20, 2017
RaySearch will be exhibiting its next-generation oncology information system (OIS) RayCare, among other highlights, at...
ProCure Proton Therapy Center New Jersey Celebrates Five-Year Cancer-Free Milestone for Prostate Cancer Patients
News | Proton Therapy | September 20, 2017
ProCure Proton Therapy Center in Somerset, N.J., recently celebrated the five-year cancer-free milestone for the first...
Varian to Showcase Latest Radiation Therapy Technologies and Software at ASTRO 2017
News | Radiation Therapy | September 19, 2017
Varian Medical Systems announced it will be demonstrating its new Halcyon platform and HyperArc high-definition...
Elekta to Highlight MOSAIQ Oncology Analytics at ASTRO Annual Meeting
News | Radiation Therapy | September 19, 2017
September 19, 2017 — Elekta will highlight its Mosaiq Oncology...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Clinical Trials and Cutting-Edge Radiation Oncology Research to Be Featured at ASTRO 2017
News | Radiation Therapy | September 14, 2017
The program for the 2017 Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 24-27 in San...
Provision Healthcare Joins RayCare Clinical Partners
News | Oncology Information Management Systems (OIMS) | September 11, 2017
Provision, located in Knoxville, Tenn., is the latest to partner with RaySearch Laboratories on the development of its...
U.K.'s NICE Supports Use of Hydrogel Spacer in Prostate Cancer Treatement
News | Patient Positioning Radiation Therapy | September 08, 2017
Augmenix Inc. announced that the National Institute for Health and Care Excellence (NICE) in the U.K. has issued...
Overlay Init